Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on: October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on:October 04,2025 0

'Rogue' DNA rings reveal earliest clues to deadly brain cancer's growth

Updated on: October 07,2025 0

'Rogue' DNA rings reveal earliest clues to deadly brain cancer's growth

Updated on:October 07,2025 0

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on: October 03,2025 0

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on:October 03,2025 0

FDA expands use of Vonvendi for von Willebrand disease

Updated on: October 01,2025 0

FDA expands use of Vonvendi for von Willebrand disease

Updated on:October 01,2025 0

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on: October 05,2025 0

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on:October 05,2025 0

Scientists identify novel therapeutic target for ovarian cancer

Updated on: October 02,2025 0

Scientists identify novel therapeutic target for ovarian cancer

Updated on:October 02,2025 0

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on: October 05,2025 0

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on:October 05,2025 0

Recommendations developed for young adult cancer survivor follow-up care

Updated on: October 06,2025 0

Recommendations developed for young adult cancer survivor follow-up care

Updated on:October 06,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on: October 05,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on:October 05,2025 0

Blocker drugs may defeat a problematic protein in synovial sarcoma's genes

Updated on: October 05,2025 0

Blocker drugs may defeat a problematic protein in synovial sarcoma's genes

Updated on:October 05,2025 0